Skip to Main Content
Committee on Science, Technology, and Law (CSTL) Committee on Science, Technology, and Law
The National Academies
The National Academies
Home ABOUT US COMMITTEE MEMBERS & STAFF CSTL NEWSLETTER ARCHIVE CSTL PROJECTS IN THE NEWS
Quick Links

Newsletter Icon

Read the latest CSTL Newsletter here.

We want to hear from you!

Comments? Opinions? Suggestions of topics for discussion? Submit them here.

 Upcoming Events

Risk and Benefits of Gain-of-Function Research: A Symposium
December 15-16, 2014
Washington, DC

Committee on Science, Technology, and Law
29th Meeting
March 12-13, 2015
Irvine, CA

Contact Us
Committee on Science, Technology, and Law
The National Academies'
Keck Center, Room 570
500 Fifth Street, NW
Washington, DC 20001
Tel: 202 334-1713
Fax: 202 334-2530


 


FORUM ON SYNTHETIC BIOLOGY

Project Scope

CSTL has established a forum for discussions about scientific, technical, ethical, legal, regulatory, security, and other policy issues associated with synthetic biology.   The forum will stimulate dialogue about issues of mutual interest to its membership by serving as a venue in which to discuss scientific advances in, challenges and opportunities for, and public policy concerns about synthetic biology.  The specific agendas for forum meetings will be determined by the forum membership.  It is expected, however, that the forum will begin its consideration of synthetic biology by addressing the near, mid- and far- term technical advances that have potential security and safety aspects and identifying possible strategies to address these aspects during both the development and post-development phases of the emerging technologies. The forum will meet three times in a period of one year with options for two additional years. It may commission papers to inform its discussions and suggest topics for studies, workshops, or other public meetings to be held in conjunction with forum meetings.

Meetings & Events

This website contains unedited verbatim presentations made by meeting participants and is not an official report of the National Academies. Opinions and statements included in this material are solely those of the individual authors. They have not been verified as accurate, nor do they necessarily represent the views of other participants, the committee, or the National Academies.

September 18-19, 2014
3rd Meeting
Washington, DC

Agenda

Presentations

*Sarah R. Carter, "Synthetic Biology and the U.S. Biotechnology Regulatory System: Challenges and Options"
*Thomas M. Connelly, "Synthetic Biology and Advanced Manufacturing - A Chemical Industry Perspective"
*Floyd Romesberg, "Artificial DNA in Living Cells"
*Frank F. Weichold, "FDA Oversight of Synthetic Biology"

March 13, 2014
2nd Meeting: Understanding Risk Frameworks for Emerging Technologies
Palo Alto, CA

Agenda
Video

Presentations

*Lynne P. Cooper, "Pre-Quantitative Risk: The Social Construction of Risk in Project Teams"
"Adam Finkel, "Channeling Synthetic Biology Through 'Solution-Focused Risk Assessment'
*Stephen Hilgartner, "The Politics of Risk"
*Sheila Jasanoff, "International Approaches to Risk (Understanding Risk Frameworks for Emerging Technologies)"
*Jennifer Kuzma, "Beyond Old Debates: New Systems Risk Analysis (NESRA) in an Action Oriented Approach"
*Andrew D. Maynard, "Innovative Approaches to Emergent Risks"
*Jonathan Wiener, "Learning from Research about Risk Regulation"

October 20-21, 2013
1st Meeting
Washington, DC

Agenda

Presentations

*Linda Chrisey, "Office of Naval Research Synthetic Biology"
*Denver Dale, "Specialized Capital Formation and Deployment to Support Synthetic Biology"
*Philip Dormitzer, "Synthetic Vaccinology at Novartis"
*Antony Evans, "Glowing Plant"
*Theresa Good, "NSF Investments in Synthetic Biology"
*Alicia Jackson, "Engineering Biology"
*Megan Palmer, "Enabling Next Generation Synthetic Biology Leadership"
*Alan Pearson, The Role of USDA-APHIS in the Regulation of Biotechnology in the United States"
*Pablo Rabinowicz, "DOE Office of Biological and Environmental Research (BER) Genomic Science Program: Biosystems Design"
*Marc Salit, "National Institute of Standards and Technology"
*Mark Segal, "EPA Oversight of Synthetic Biology"
*William So, "Synthetic Biology and National Security"

August 16, 2013
The Evolving Nature of Synthetic Biology: A Panel Discussion on Key Science, Policy, and Societal Challenges Facing the International Community
Washington, DC

Agenda
Video

Presentations

*Drew Endy, "What and Why Is Synthetic Biology"
*Richard Johnson, "Synthetic Biology: Ten Policy Reasons It Matters to U.S. Foreign Policy"
*Eleonore Pauwels, "Lost in Translation: Sharing Knowledge on the Technological Frontier"

August 1, 2013
Virtual Meeting

This meeting was closed in its entirety.

July 15-16, 2013
Ownership and Sharing: Setting the Patent Framework for Innovation in Synthetic Biology, A Workshop
London, England

Meeting Summary

Agenda

Presentations

*Robert Wells, Synthetic Biology and the Bioeconomy
*Rob Carlson, The Bioeconomy, IP, and Synthetic Biology
*Rochelle C. Dreyfuss, The Patent Landscape: Recent Decisions from the U.S. Supreme Court
*Linda Kahl, How Synthetic Biology Challenges Current Patenting/Ownership Frameworks
*Joanne Kamens, Addgene: A Unique Non-Profit Biotech
*Drew Endy, From Genetic Engineering to Synthetic Biology
*Lionel Clarke, Synthetic Biology Ownership and Innovation: Industry and Other Perspectives
*Stephen Laderman, Case Study: Agilent Technologies - Freedom to Operate
 

  Project Information  

PROJECT STAFF

Anne-Marie Mazza, Ph.D.
Director, Committee on Science, Technology, and Law
Phone: 202-334-2469
E-mail:
amazza@nas.edu

Steven Kendall, Ph.D.
Program Officer, Committee on Science, Technology, and Law
Phone: 202-334-1713
E-mail: skendall@nas.edu

Karolina Konarzewska
Program Assistant, Committee on Science, Technology, and Law
Phone: 202-334-2455
E-mail: kkonarzewska@nas.edu


Reports

Summaries of the proceedings of forum activities may be published as NRC reports. 

MEMBERSHIP

Co-chairs:

Vicki L. Chandler (NAS)
Chief Program Officer, Science
Gordon and Betty Moore Foundation

Richard M. Murray (NAE) 
Thomas E. and Doris Everhart Professor of Control and Dynamical Systems and Bioengineering  
California Institute of Technology  

Members:

Steven A. Benner  
Director  
The Foundation for Applied Molecular Evolution (Ffame) 

Jef D. Boeke (NAS)
Director
Institute for Systems Genetics
New York University Langone School of Medicine

Rob Carlson   
Principal   
Biodesic LLC 

R. Alta Charo (IOM)  
Warren P. Knowles Professor of Law and Bioethics   
Department of Medical History and Bioethics
School of Medicine and Public Health
University of Wisconsin-Madison
 
Laura K. Donohue   
Professor of Law   
Georgetown University Law Center  

Drew Endy   
Assistant Professor, Bioengineering
Stanford University

President
The BioBricks Foundation   

Richard A. Johnson  
Chief Executive Officer   
GlobalHelix LLC 

Claire Marris  
Senior Research Fellow
Department of Social Science, Health and Medicine  
Kings College London  

Darlene J.S. Solomon   
Senior Vice President and Chief Technology Officer   
Agilent Technologies  

Ex Officio Members:

Linda Chrisey  
Program Officer  
Office of Naval Research 

Genya Dana
Office of the Science and Technology Adviser to the Secretary
U.S. Department of State

Barbara Gerratana
Program Director
National Institute of General Medical Sciences 

Theresa Good
Program Director  
National Science Foundation

Alicia Jackson
Deputy Director
Biological Technologies Office
Defense Advanced Research Projects Agency

Marc Salit
Group Leader  
National Institute of Standards and Technology 

Jessica M. Tucker 
Program Director
National Institute of Biomedical Imaging and Bioengineering

Edward You
Supervisory Special Agent  
Federal Bureau of Investigation 

Sponsors

This project is sponsored by the Alfred P. Sloan Foundation and Agilent Technologies.